期刊文献+

川崎病临床诊断研究进展 被引量:5

Research on the Update Development of Kawasaki Disease Clinical Diagnosis
下载PDF
导出
摘要 川崎病自1961年至今已有50余年,病因学研究尚未得出详细致病机制。川崎病的临床诊断分为3型。到目前为止,KD的致病机制上还存在各种假说,治疗方法上,还存在相互有矛盾的报道,需要我们更深入的研究。就KD患者而言,尽可能及时确诊和治疗,能有效减少冠脉病变的发生及发展。 Kawasaki disease has been reported more than 50 years since 1961,but the mechanisms has been unknown till nowadays by means of etiologies. Three types of Kawasaki disease have been identified according to clinical diagnosis. So far,there are still a variety of pathogenic mechanism of KD hypothesis,treatment methods. There are mutually contradictory reports,which need to further study. As much as possible,in terms of KD patients,timely diagnosis and treatment,can effectively reduce the occurrence of coronary artery lesions and development.
作者 江平 洪山
出处 《山西职工医学院学报》 CAS 2017年第1期57-59,共3页 Journal of Shanxi Medical College for Continuing Education
关键词 川崎病 不典型性川崎病 不完全性川崎病 IVGG无反应型川崎病 Kawasaki disease atypical Kawasaki disease incomplete Kawasaki disease non-responses Kawasaki disease
  • 相关文献

参考文献3

二级参考文献35

  • 1Newburger JW, Takahoshi M, Gerber MA, et al. Diagnosis,treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.Circulation, 2004,110:2747-2771.
  • 2Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr International, 2005,47:711-732.
  • 3Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med, 1995,163:322 -327.
  • 4Sande RP, Baker AL, Fulton DR, et al. Corticosteroids in the initial treatment of Kawasaki disease:report of a randomized trial. J Pediatr,2003,142:611-616.
  • 5Saulsbury FT. Comparison of high - dose and low - dose aspirin plus intravenous immunoglobulin in the treatment of kawasaki syndrome [J]. Clin Pediatr (Phila) ,2002,41 (8):597 - 601.
  • 6Khowsathit P, Hong- Hgam C, Khositseth A, et al. Treatment of Kawasaki disease with a moderate dose (1g/kg) of intravenous immunoglobulin[J]. J Med Assoc Thai, 2002, 85 (suppl): S1121-S1126.
  • 7Terai M, Shulman ST. Prevalence of coronary artery abnormalities in kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose [J]. J Pediatr, 1997, 131 (6): 888 -893.
  • 8Nishikawa M, Ichiyama T, Hasegawa M, et al. Safety from thromboembolism using intravenous immunoglobulin therapy in kawasaki disease: study of whole - blood viscosity[J]. Pediatr Int, 2003,45(2): 156- 158.
  • 9French JW, Kahn SJ. Initial intravenous gammaglobulin treatment failure in kawasaki disease[J]. Pediatrics,2000,105(6) :78.
  • 10Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin- resistant Kawasaki disease with pulsed doses of corticosteroids[J]. J Pediatr, 1996,128(1): 146 - 149.

共引文献68

同被引文献35

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部